Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment

This paper reviews current treatments for renal cell carcinoma/cancer (RCC) with the multikinase inhibitors (MKIs) sorafenib, sunitinib, lenvatinib and axitinib. Furthermore, it compares these drugs regarding progression-free survival, overall survival and adverse effects (AE), with a focus on hyper...

Descripción completa

Detalles Bibliográficos
Autores principales: Bæk Møller, Nanna, Budolfsen, Cecilie, Grimm, Daniela, Krüger, Marcus, Infanger, Manfred, Wehland, Markus, E. Magnusson, Nils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801695/
https://www.ncbi.nlm.nih.gov/pubmed/31547602
http://dx.doi.org/10.3390/ijms20194712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801695/
https://www.ncbi.nlm.nih.gov/pubmed/31547602
http://dx.doi.org/10.3390/ijms20194712

Ejemplares similares